Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Revenue (2020 - 2025)

Historic Revenue for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $10.4 million.

  • KORU Medical Systems' Revenue rose 2716.62% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.1 million, marking a year-over-year increase of 2211.94%. This contributed to the annual value of $33.6 million for FY2024, which is 1798.46% up from last year.
  • Latest data reveals that KORU Medical Systems reported Revenue of $10.4 million as of Q3 2025, which was up 2716.62% from $10.2 million recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Revenue registered a high of $10.4 million during Q3 2025, and its lowest value of $5.4 million during Q1 2021.
  • In the last 5 years, KORU Medical Systems' Revenue had a median value of $7.3 million in 2022 and averaged $7.6 million.
  • Within the past 5 years, the most significant YoY rise in KORU Medical Systems' Revenue was 5997.42% (2021), while the steepest drop was 2828.85% (2021).
  • Quarter analysis of 5 years shows KORU Medical Systems' Revenue stood at $6.5 million in 2021, then grew by 13.16% to $7.3 million in 2022, then decreased by 2.16% to $7.2 million in 2023, then rose by 23.0% to $8.8 million in 2024, then grew by 17.69% to $10.4 million in 2025.
  • Its last three reported values are $10.4 million in Q3 2025, $10.2 million for Q2 2025, and $9.6 million during Q1 2025.